Endocrine therapy use among Medicaid-insured breast cancer survivors with hormone receptor-positive tumors

被引：0
|
作者：
Kohler, Racquel Elizabeth
Wheeler, Stephanie B.
Reeder-Hayes, Katherine Elizabeth
Goyal, Ravi K.
Lich, Kristen Hassmiller
Smith, Timothy
Melvin, Cathy
Moore, Alexis
Muss, Hyman Bernard
机构：
[1] Univ N Carolina, Chapel Hill, NC USA
[2] Cecil G Sheps Ctr Hlth Serv Res, Chapel Hill, NC USA
[3] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6017
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Survival disadvantage among Medicaid-insured breast cancer patients treated with breast conserving surgery without radiation therapy
    Kristie Long Foley
    Gretchen Kimmick
    Fabian Camacho
    Edward A. Levine
    Rajesh Balkrishnan
    Roger Anderson
    [J]. Breast Cancer Research and Treatment, 2007, 101 : 207 - 214
  • [42] Neoadjuvant endocrine therapy for estrogen receptor-positive primary breast cancer
    Yamamoto, Yutaka
    Goto-Yamaguchi, Lisa
    Takeno, Masako
    Yamamoto-Ibusuki, Mutsuko
    [J]. CHINESE CLINICAL ONCOLOGY, 2020, 9 (03) : 30
  • [43] microRNA Regulation in Estrogen Receptor-Positive Breast Cancer and Endocrine Therapy
    Erin W. Howard
    Xiaohe Yang
    [J]. Biological Procedures Online, 2018, 20
  • [44] microRNA Regulation in Estrogen Receptor-Positive Breast Cancer and Endocrine Therapy
    Howard, Erin W.
    Yang, Xiaohe
    [J]. BIOLOGICAL PROCEDURES ONLINE, 2018, 20
  • [45] Targeted Therapies Overcoming Endocrine Resistance in Hormone Receptor-Positive Breast Cancer
    Almstedt, Katrin
    Schmidt, Marcus
    [J]. BREAST CARE, 2015, 10 (03) : 168 - 172
  • [46] New Targets in Endocrine-Resistant Hormone Receptor-Positive Breast Cancer
    Kennedy, Laura C.
    Mayer, Ingrid A.
    [J]. CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2021, 19 (08) : 511 - 521
  • [47] Safety of adjuvant endocrine therapies in hormone receptor-positive early breast cancer
    Sehdev, S.
    Martin, G.
    Sideris, L.
    Lam, W.
    Brisson, S.
    [J]. CURRENT ONCOLOGY, 2009, 16 : S16 - S25
  • [48] Preoperative endocrine therapy with goserelin acetate and tamoxifen in hormone receptor-positive premenopausal breast cancer patients
    Shimizu, Daisuke
    Ishikawa, Takashi
    Tanabe, Mikiko
    Sasaki, Takeshi
    Ichikawa, Yasushi
    Chishima, Takashi
    Endo, Itaru
    [J]. BREAST CANCER, 2014, 21 (05) : 557 - 562
  • [49] Endocrine therapy for hormone receptor-positive, HER2-negative metastatic breast cancer: extending endocrine sensitivity
    Frassoldati, Antonio
    Biganzoli, Laura
    Bordonaro, Roberto
    Cinieri, Saverio
    Conte, Pierfranco
    De Laurentis, Michelino
    Del Mastro, Lucia
    Gori, Stefania
    Lauria, Rossella
    Marchetti, Paolo
    Michelotti, Andrea
    Montemurro, Filippo
    Naso, Giuseppe
    Pronzato, Paolo
    Puglisi, Fabio
    Tondini, Carlo Alberto
    [J]. FUTURE ONCOLOGY, 2020, 16 (05) : 129 - 145
  • [50] Neoadjuvant endocrine therapy for postmenopausal patients with hormone receptor-positive early breast cancer: a new concept
    Hiroji Iwata
    [J]. Breast Cancer, 2011, 18 : 92 - 97
12345